Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04188392 · ClinicalTrials.gov registry record · Phase 4
Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder
A Phase 4 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT04188392 is a Phase 4 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 6 participants.
The verdict
NCT04188392, a Phase 4 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
This preliminary, open-label study assesses the feasibility of 34mg at bedtime for 6 weeks in Veterans with Posttraumatic Stress Disorder and insomnia.
Interventions
- DRUG Pimavanserin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2021-11-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04188392
The ClinicalTrials.gov registry entry for NCT04188392 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pimavanserin is the first listed.
NCT04188392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04188392 about?
NCT04188392 is a clinical study titled "Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder". This preliminary, open-label study assesses the feasibility of 34mg at bedtime for 6 weeks in Veterans with Posttraumatic Stress Disorder and insomnia.
What is the current status of trial NCT04188392?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2020-01-06. Estimated completion is 2021-11-10.
What interventions are being tested in trial NCT04188392?
The interventions under investigation include: Pimavanserin (DRUG).
Who is sponsoring clinical trial NCT04188392?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.